Increasing incidence of methicillin-resistant Staphylococcus aureus in hand infections: A 3-year county hospital experience

Plastic and Reconstructive Surgery

Volumn 119, Issue 3, 2007, Pages 935-940

  LeBlanc, Danielle M ^a   Reece, Edward M ^a   Horton, J Bauer ^a   Janis, Jeffrey E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; GENTAMICIN; LEVOFLOXACIN; METICILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ABSCESS; ABSCESS DRAINAGE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; FEMALE; FINGER; FOLLOW UP; HAND INFECTION; HOSPITAL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PENICILLIN RESISTANCE; PERSONAL EXPERIENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; AGED; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HAND; HUMANS; INCIDENCE; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33847203317     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000252270.84195.41     Document Type: Article

References (22)

1. Moreno, F., Crisp, C., Jorgensen, J. H., and Patterson, J. E. Methicillin-resistant Staphylococcus aureus as a community organism. Clin. Infect. Dis. 21: 1308, 1995.
2. Iyer, S., and Jones, D. H. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: A retrospective analysis of clinical presentation and treatment of a local outbreak. J. Am. Acad. Dermatol. 50: 854, 2004.
3. Baillargeon, J., Kelley, M. F., Leach, C. T., Baillargeon, G., and Pollock, B. H. Methicillin-resistant Staphylococcus aureus infection in the Texas prison system. Clin. Infect. Dis. 38: e92, 2004.
4. Cohen, P. R., and Kurzrock, R. Community-acquired methicillin-resistant Staphylococcus aureus skin infection: An emerging clinical problem. J. Am. Acad. Dermatol. 50: 277, 2004.
5. Lindenmayer, J. M., Schoenfeld, S., O'Grady, R., and Carney, J. K. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch. Intern. Med. 158: 895, 1998.
6. Fridkin, S. K., and Gaynes, R. P. Antimicrobial resistance in intensive care units. Clin. Chest Med. 20: 303, 1999.
7. Smith, T. L., Pearson, M. L., Wilcox, K. R., et al. Emergence of vancomycin resistance in Staphylococcus aureus: Glycopeptide-Intermediate Staphylococcus aureus Working Group. N. Engl. J. Med. 340: 493, 2002.
8. Enright, M. C. The evolution of a resistant pathogen: The case of MRSA. Curr. Opin. Pharmacol. 3: 474, 2003.
9. Naimi, T. S., LeDell, K. H., Como-Sabetti, K., et al. Comparison of community and health-care associated MRSA infection. J.A.M.A. 290: 2976, 2003.
10. Herold, B. C., Immergluck, L. C., Maranan, M. C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. J.A.M.A. 279: 593, 1998.
11. Sattler, C. A., Mason, E. O., Jr., and Kaplan, S. L. Prospective comparison of risk factors and demographics and clinical characteristics of community-acquired MRSA in children. Pediatr. Infect. Dis. J. 21: 910, 2002.
12. Eady, E. A., and Cove, J. H. Staphylococcal resistance revisited: Community-acquired methicillin resistant Staphylococcus aureus. An emerging problem for the management of skin and soft tissue infections. Curr. Opin. Infect. Dis. 16: 103, 2003.
13. Kopp, B. J., Nix, D. E., and Armstrong, E. P. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann. Pharmacother. 38: 1377, 2004.
14. Engemann, J. J., Carmeli, Y., Cosgrove, S. E., et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin. Infect. Dis. 36: 592, 2003.
15. Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., and Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta analysis. Clin. Infect. Dis. 36: 53, 2003.
16. Llera, J. L., and Levy, R. C. Treatment of cutaneous abscess: A double-blind clinical study. Ann. Emerg. Med 14: 15, 1985.
17. Lee, M. C., Rios, A. M., Aten, M. F., et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr. Infect. Dis. J. 23: 123, 2004.
18. Stevens, D. L., Herr, D., Lampiris, H., Hunt, J. L., Batts, D. H., and Hafkin, B. Linezolid versus vancomycin for the treatment of methicillin- resistant Staphylococcus aureus infections. Clin. Infect. Dis. 34: 1481, 2002.
19. Fung, H. B., Chang, J. Y., and Kuczynski, S. Practical guide to the treatment of complicated skin and soft tissue infections. Drugs 63: 1459, 2003.
20. Li, J. Z., Willke, R. J., Rittenhouse, B. E., and Rybak, M. J. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: Results from a randomized clinical trial. Surg. Infect. 4: 57, 2003.
21. Mutnick, A. H., Enne, V., and Jones, R. N. Linezolid resistance since 2001: SENTRY antimicrobial surveillance program. Ann. Pharmacother. 37: 769, 2003.
22. Raghavan, M., and Linden, P. K. Newer treatment options for skin and soft tissue infections. Drugs 64: 1621, 2004.